Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 28

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Role of PMC (2,2,5,7,8-pentamethyl-6-chromanol), a sterically hindered phenol, in rescuing oxidized low-density lipoprotein (ox-LDL) induced cytotoxicity in human retinal pigment epithelial cells

Suman Chaudhary; Daisy Y Shu; Maria Chiara Rivolta; Emil Kriukov; Sergio Pestun; Petr Y Baranov; Yin Shan Eric Ng; Patricia A D'Amore

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6515.

ARVO Annual Meeting Abstract June 2023

Endomucin deletion leads to disorganized choroidal capillary fenestration and reduces laser-induced choroidal neovascularization in mice

Zhengping Hu; Issahy Cano; Anton Lennikov; Melissa Wild; Urvi Gupta; Yin Shan Eric Ng; Patricia A D'Amore

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3005.

ARVO Annual Meeting Abstract June 2022

Therapeutic effect of hindered phenol compound in a solid lipid nanoparticle formulation in mouse models of dry AMD

Yin Shan Eric Ng; Zhenyu Ji; Anthoula Arta; Yu Su; Andrew James Urquhart; Patricia A D'Amore

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4286.

ARVO Annual Meeting Abstract June 2022

Endomucin deletion delays retinal vascular development and inhibits neovascularization in oxygen-induced retinopathy

Zhengping Hu; Issahy Cano; Magali Saint-Geniez; Yin Shan Eric Ng; Patricia A D'Amore

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3167 – F0441.

ARVO Annual Meeting Abstract June 2021

Specific Role of Endomucin in VEGF-induced VEGF Receptor 2 Internalization and Function

Zhengping Hu; Issahy Cano; Magali Saint-Geniez; Yin Shan Eric Ng; Patricia A D'Amore

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2925.

ARVO Annual Meeting Abstract June 2021

Galectin-3 requires VEGF to activate VEGF receptor 2 in retinal endothelial cells

Issahy Cano; Zhengping Hu; Dina Abusamra; Magali Saint-Geniez; Yin Shan Eric Ng; Pablo Argueso; Patricia A D'Amore

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2702.

ARVO Annual Meeting Abstract June 2021

Therapeutic effects of recombinant heparin-binding domain protein in a mouse model of diabetic retinopathy

Zhenyu Ji; Yu Su; Ashley Mackey; Yin Shan Eric Ng

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1082.

ARVO Annual Meeting Abstract June 2020

Therapeutic effects of recombinant heparin-binding domain (HBD) protein on VEGF-induced pathological leukostasis and angiogenesis in mouse models.

Zhenyu Ji; Yu Su; Ashley Mackey; Yin Shan Eric Ng

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1170.

ARVO Annual Meeting Abstract July 2019

Endomucin and galectin-3 modulate VEGFR2-mediated endothelial functions

Michelle LeBlanc; Issahy Cano; Zhengping Hu; kahira Saez-Torres; Magali Saint-Geniez; Yin Shan Eric Ng; Pablo Argueso; Patricia A. D'Amore

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3259.

ARVO Annual Meeting Abstract July 2019

Endomucin regulates Vascular Endothelial Growth Factor (VEGF) induced endothelium functions through its extracellular domain

Zhengping Hu; Michelle LeBlanc; kahira Saez-Torres; Magali Saint-Geniez; Yin Shan Eric Ng; Patricia A. D'Amore

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5376.

ARVO Annual Meeting Abstract July 2019

Solid lipid nanoparticles for the delivery of a sustained-release small molecule antioxidant for RPE protection in dry AMD

Anthoula Arta; Yu Su; Franco Aparecido Rossato; Gopalan Gnanaguru; Patricia A. D'Amore; Yin Shan Eric Ng; Andrew J Urquhart

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1705.

ARVO Annual Meeting Abstract July 2019

Bacterial infection promotes spontaneous choroidal neovascularization (sCNV) development in the JR5558 mouse

YU SU; Franco Aparecido Rossato; Yin Shan Eric Ng

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4902.

ARVO Annual Meeting Abstract July 2018

Systematic treatment with trimethoprim/sulfamethoxazole (Ditrim) significantly inhibits spontaneous choroidal neovascularization (sCNV) in the JR5558 mouse model

YU SU; Franco Rossato; Ashley Mackey; Yin Shan Eric Ng

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):70.

ARVO Annual Meeting Abstract July 2018

Targeting endothelial-to-mesenchymal transition (EndMT) driven fibrosis for choroidal neovascularization (CNV) in age-related macular degeneration (AMD)

Franco Aparecido Rossato; Yu Su; Ashley Mackey; Yin Shan Eric Ng

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2629.

ARVO Annual Meeting Abstract July 2018

Endomucin (EMCN) Regulates Angiogenesis by Controlling VEGFR2 Endocytosis

Michelle LeBlanc; Kahira Saez-Torres; Magali Saint-Geniez; Yin Shan Eric Ng; Patricia A D'Amore

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5481.

ARVO Annual Meeting Abstract July 2018

Novel engineered VEGF variant for glaucoma

Junhui Shen; Petr Baranov; Ru Xiao; Yin Shan Eric Ng

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6130.

ARVO Annual Meeting Abstract June 2017

The PPAR-γ Agonist Troglitazone Protects RPE Cells from Oxidized LDL Induced NLRP3-inflammasome–Mediated Cell Death

Ashley Mackey; Gopalan Gnanaguru; Eun Young Choi; Dhanesh Amarnani; Patricia A D'Amore; Yin Shan Eric Ng

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2288.

ARVO Annual Meeting Abstract June 2017

The role of fibrosis and endothelial mesenchymal transition (EndoMT) in choroidal neovascularization (CNV) pathogenesis.

Franco Aparecido Rossato; Ashley Mackey; Yin Shan Eric Ng

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4077.

ARVO Annual Meeting Abstract September 2016

Investigation of VEGF165 induced retinal vascular inflammation in vitro

Ashley Mackey; Yin Shan Eric Ng

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3199.

ARVO Annual Meeting Abstract September 2016

Endomucin inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by suppressing VEGFR2 signaling

Patricia A D'Amore; Cindy Park-Windhol; Yin Shan Eric Ng; Jinling Yang; Vincent Primo; Magali Saint-Geniez

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3637.

1 2

Next 20 Results »

Advertisement